Capital One Financial COF Commercial Banking — Goodwill, Other Increase (Decrease)

Other segment segments

Credit Card

-$7M-164%

Consumer Banking

$0—

Similar metrics at other companies

HBANCommercial Banking — Goodwill, Other Increase (Decrease)

-$33M—

HBANConsumer & Regional Banking — Goodwill, Other Increase (Decrease)

$0—

WBSCommercial Banking — Goodwill

$1.96B0.0%

WFCCommercial Banking — Goodwill

$2.93B-0.1%

FITBCommercial Banking — Goodwill

$2.28B—

UMBFCommercial Banking — Goodwill

$1.04B+6.5%

Other financials

Income statement

See full

Revenue$15.9B+26.9%

Net income$3.0B+171%

EPS (diluted)$4.73+155%

Balance sheet

See full

Cash & equivalents$55.9B-9.3%

Total debt$46.1B-13.7%

Total equity$113.79B+2.6%

Total assets$673.84B+2.3%

Cash flow

See full

Operating cash flow$8.4B+39.2%

CapEx$367.0M-8.0%

Free cash flow$8.1B+42.5%

Valuation

See full

Market cap$127.03B-7.3%

Enterprise value$117.21B-9.0%

P/E12.1×—

P/S2.1×-1.2×

Profitability

See full

Net margin17%—

FCF margin47.9%+5.2pp

Returns & leverage

See full

Return on equity9.4%—

Debt / equity0.4×-0.1×

Where this comes from

Reported directly by Capital One Financial in its filing.

Tagged under the XBRL concept us-gaap:GoodwillOtherIncreaseDecrease.

The official record: Capital One Financial’s 10-Q, filed July 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capital One Financial's commercial banking — goodwill, other increase (decrease).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Capital One Financial's commercial banking — goodwill, other increase (decrease)?: Capital One Financial (COF) reported commercial banking — goodwill, other increase (decrease) of $0 in Q2 2026.
What does commercial banking — goodwill, other increase (decrease) mean?: Reflects the net periodic adjustments to the carrying value of goodwill and other intangible assets within the commercial banking segment. These adjustments typically arise from annual impairment testing or changes in the valuation of acquired assets.